Molecular Partners AG Files 6-K with Press Release

Ticker: MOLN · Form: 6-K · Filed: Jun 12, 2025 · CIK: 1745114

Sentiment: neutral

Topics: filing, press-release, registration-statement

Related Tickers: MPRS

TL;DR

MPRS files 6-K, check the press release for news.

AI Summary

Molecular Partners AG filed a Form 6-K on June 12, 2025, to furnish a press release issued on June 10, 2025. This filing incorporates the press release by reference into its existing Registration Statements on Form F-3 and Form S-8.

Why It Matters

This filing indicates the company is providing updated information to the SEC, which may contain material developments relevant to investors.

Risk Assessment

Risk Level: low — The filing is a routine submission of a press release and does not appear to contain new or significant negative information.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to furnish a press release that Molecular Partners AG issued on June 10, 2025.

When was the press release furnished to the SEC?

The press release was furnished to the SEC on June 12, 2025, as part of this Form 6-K filing.

Into which registration statements is the press release incorporated by reference?

The press release is incorporated by reference into Molecular Partners AG's Registration Statements on Form F-3 (File No. 333-286488) and Form S-8.

What is the principal executive office address of Molecular Partners AG?

The principal executive office address of Molecular Partners AG is Wagistrasse 14, 8952 Zürich-Schlieren, Switzerland.

What is the SIC code for Molecular Partners AG?

The Standard Industrial Classification (SIC) code for Molecular Partners AG is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 12, 2025 regarding MOLECULAR PARTNERS AG (MOLN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing